Toggle navigation
HOME
OPERATIONS MANUAL
CODE OF ETHICS FOR AUTHORS
STATEMENT ON THE USE OF AI
CODE OF CONDUCT FOR REVIEWERS
EDITORIAL POLICIES
BROWSE
CURRENT ISSUE
AHEAD OF PRINT
EDITORIAL BOARD
AUTHORS
INSTRUCTIONS
CONTACT
OPEN ACCESS
Paola Maycotte-González
Centro de Investigación Biomédica de Oriente, IMSS, Puebla, Pue., México
Evaluation of molecular classification by immunohistochemistry in advanced breast cancer treated with epirubicin and docetaxel: clinical, pathological, therapeutic and prognostic differences
Nicolás Ramírez-Torres, Paola Maycotte-González, Rodolfo Rivas-Ruiz
VOLUME 17 - NUMBER 1 /
January - March
Close
